Pediatric Drug Development Solutions 2000
2) In general, children who can give assent should be enrolled in a study in preference to, or prior to, children who cannot give assent. Careful consideration must be given to the importance of the potential benefit of the study. In certain circumstances, the potential benefit that may be derived from studying children who cannot give assent may override the preference for first enrolling assenting children.